Comparative studies of glycoprotein Ib in heparin coated and nonheparin coated extracorporeal circulation circuits.
Contact between blood and artificial materials has various effects on blood. Impairment of platelet function is an especially important and well known effect, but its precise mechanism is not clearly understood. The authors constructed a circulation model to investigate the effect of extracorporeal circulation on platelet membrane glycoproteins (GPs), especially GP Ib, and to compare the changes in GP Ib in heparin coated (group C) and nonheparin coated (group N) circuits. As determined by flow cytometry, GP Ib in both groups decreased on initiating circulation, but the decrease in group N was significantly larger than that in group C. There was no observed change in GP IIb/IIIa levels in either group. The extent of shear stress induced platelet aggregation significantly decreased during circulation in both groups. Decreases in the extent of shear stress induced platelet aggregation were significantly less with the use of heparin coated circuits. In addition, the amount of GP Ib in the high speed pellet decreased progressively during circulation in both groups. In contrast, the amount of GP Ib in the Triton insoluble (low speed) pellet increased dramatically during circulation. However, expression of GP Ib in the Triton soluble platelet fraction was low in both groups. From the results, it was concluded that the cause of the decrease in platelet function during extracorporeal circulation is attributable to the internalization of GP Ib from the platelet surface inside the platelet. It also can be said that a heparin coated circuit is one effective means of controlling this change.
Hioki
I
I
Department of Thoracic and Cardiovascular Surgery, Mie University School of Medicine, Tsu, Japan.
Yada
I
I
Nishikawa
M
M
Shomura
Y
Y
Cruz
B P
BP
Onoda
K
K
Tani
K
K
Shimono
T
T
Shinpo
H
H
D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D004867:Equipment Design; D005112:Extracorporeal Circulation / Q000295:instrumentation*; D006493:Heparin / Q000494:pharmacology; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000502:physiology*
D019038:Platelet Glycoprotein GPIb-IX Complex; D006493:Heparin